Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,785,356
+$408,166 QoQ
Shares Held
10,443
+0.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#143
of 307 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International, Inc./CA/ holds $249,590,047 across 7 Biotechnology names. ASND ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
305,477 | $87,051,780 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
164,407 | $81,665,889 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,074,948 | $60,272,334 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,154 | $8,202,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
25,671 | $7,727,741 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
10,443 | $2,785,356 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
34,560 | $1,884,902 |
All Filings in ASND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,785,356 | 10,443 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,377,190 | 10,393 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,933,020 | 9,065 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,082,534 | 10,475 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,683,367 | 9,753 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,394,947 | 8,950 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,152,986 | 8,375 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||